| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT06963827 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy |
Trial sites expanded: 163 -> 166 locations |
| 2026-05-30 | NCT06963827 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy |
Trial sites expanded: 158 -> 163 locations |
| 2026-05-23 | NCT06722235 A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia |
date change Primary completion pushed: 2027-12-28 -> 2028-03-16 |
| 2026-05-23 | NCT06722235 A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia |
date change Completion pushed: 2027-12-28 -> 2028-03-16 |
| 2026-05-21 | NCT06963827 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy |
Trial sites expanded: 154 -> 158 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07613359 A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06722235 | A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia | Immune Thrombocytopenic Purpura (ITP) | Recruiting |
| NCT06963827 | A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy | Kidney Disease | Recruiting |
| NCT06948318 | A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia | Immune Thrombocytopenic Purpura (ITP) | Recruiting |
| Phase 2 | |||
| NCT07613359 | A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a… | Antibody-Mediated Rejection (AMR) | Not Yet Recruiting |